Successors and Assigns Clause Example from Business Contracts

This example Successors and Assigns clause appears in 20 contracts from 13 companies

Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the Company and the Agent and their respective successors and the affiliates, controlling persons, officers and directors referred to in Section 11 hereof. References to any of the parties contained in this Agreement shall be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective succe...ssors and permitted assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party. View More
Found in Moleculin Biotech, Inc. contract
EyePoint Pharmaceuticals, Inc. Contracts

At Market Issuance Sales Agreement, dated January 18, 2019, between EyePoint Pharmaceuticals, Inc. and B. Riley FBR, Inc (Filed With SEC on January 18, 2019)

HEAT BIOLOGICS, INC. Contracts

At Market Issuance Sales Agreement, dated April 3, 2019, by and between Heat Biologics, Inc. and B. Riley FBR, Inc (Filed With SEC on April 4, 2019)

At Market Issuance Sales Agreement, dated August 15, 2016, by and between Heat Biologics, Inc. and FBR Capital Markets & Co (Filed With SEC on August 15, 2016)

MEDICINOVA INC Contracts

At Market Issuance Sales Agreement, dated August 23, 2019, by and between MediciNova, Inc. and B. Riley FBR, Inc (Filed With SEC on August 23, 2019)

Moleculin Biotech, Inc. Contracts

At Market Issuance Sales Agreement, dated July 23, 2019, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 24, 2019)

At Market Issuance Sales Agreement, dated July 17, 2020, by and among the Company and Oppenheimer & Co. Inc (Filed With SEC on July 17, 2020)

MOLECULIN BIOTECH, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 25, 2021)

VICAL INC Contracts

At Market Issuance Sales Agreement, dated April 14, 2020, by and between the Company and Oppenheimer & Co. Inc (Filed With SEC on April 14, 2020)

Tocagen Inc Contracts

At Market Issuance Sales Agreement between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on September 4, 2020)

At Market Issuance Sales Agreement between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 1, 2022)

ARTELO BIOSCIENCES, INC. Contracts

At Market Issuance Sales Agreement between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 9, 2021)

Ra Medical Systems, Inc. Contracts

At Market Issuance Sales Agreement by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on September 2, 2022)

Sachem Capital Corp. Contracts

At Market Issuance Sales Agreement between Sachem Capital Corp. and B. Riley FBR, Inc., dated November 9, 2018 (Filed With SEC on November 9, 2018)

BROADWIND ENERGY, INC. Contracts

At Market Issuance Sales Agreement, dated July 31, 2018, by and among the Company and Roth Capital Partners, LLC (Filed With SEC on July 31, 2018)

Cherry Hill Mortgage Investment Corp Contracts

At Market Issuance Sales Agreement, dated August 31, 2018, between Cherry Hill Mortgage Investment Corporation and JMP Securities LLC (Filed With SEC on August 31, 2018)

At Market Issuance Sales Agreement, dated August 31, 2018, between Cherry Hill Mortgage Investment Corporation and B. Riley FBR, Inc (Filed With SEC on August 31, 2018)

Sales Agreement, dated April 5, 2018, between Cherry Hill Mortgage Investment Corporation and B. Riley FBR, Inc (Filed With SEC on April 5, 2018)

Sales Agreement, dated April 5, 2018, between Cherry Hill Mortgage Investment Corporation and JMP Securities LLC (Filed With SEC on April 5, 2018)

OMEROS CORP Contracts

OMEROSCORPORATION Common Stock (par value $0.01 per share) AtMarket Issuance Sales Agreement (Filed With SEC on January 6, 2016)

Synthetic Biologics, Inc. Contracts

SYNTHETIC BIOLOGICS, INC. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on August 5, 2016)